Q3 2020 Sales Performance

23andMe and GSK exclusive collaboration gsk Collaboration offers scale, diversity, sustainability for advancing therapeutic programs Questionnaire yields unique phenotype information vs other biobanks Can deploy custom surveys to dive deeper into specific diseases Allows rapid recruitment of clinical trials based on genotype, phenotype and proximity to study centres Improved target selection (higher PoS, and safer, more effective medicines) Allows more efficient/effective identification and recruitment of patients for clinical studies Empowers patients! POS: probability of success 42 42

View entire presentation